Other researchers delving into this trial also noticed that the peptide may have interacted with VEGF and Transforming Growth Factor Beta 1 (TGF-1)
MEDICAL ADVICE DISCLAIMER: Nothing in this article constitutes medical advice
If you notice signs of anaphylaxisswelling of your tongue, face, or throat, difficulty breathing, or difficulty swallowingafter getting a B12 injection, call 911 or head to the closest emergency room immediately
Results vary, and a consultation helps determine whether B12 is the right tool for your specific situation or whether another treatment is a better fit
Phase 2 trial results by dose (48 weeks) Phase 3 TRIUMPH-4 results (68 weeks) The phase 3 TRIUMPH-4 data, released in early 2026, confirmed and exceeded the phase 2 results
5-Amino-1MQ is a small-molecule compound supplied in a 10 mg format for laboratory and in-vitro research applications